BREAST DUCTAL CARCINOMA IN SITU
Clinical trials for BREAST DUCTAL CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST DUCTAL CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST DUCTAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a vaccine before surgery stop breast cancer?
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase trial tests a vaccine called H2NVAC in people with a very early form of breast cancer called DCIS that has the HER2 protein. The vaccine is given before surgery to see if it can train the immune system to fight the cancer. The main goals are to check for side eff…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:10 UTC
-
Fasting during chemo: a new way to boost treatment?
Disease control Recruiting nowThis trial tests whether time-restricted eating (TRE) — a 16:8 fasting schedule — is feasible for patients with HER2-negative breast cancer undergoing neoadjuvant chemotherapy. Participants will follow TRE for 16 weeks while receiving chemo, and researchers will measure how many …
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can cutting calories boost Radiation's power against breast cancer?
Disease control Recruiting nowThis study is testing whether adding calorie restriction to a precise, high-dose radiation treatment (SABR) before surgery can shrink breast tumors more than radiation alone. About 80 adults with early-stage breast cancer will be randomly assigned to either standard dietary advic…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Glowing needle could spot hidden breast tumors in real time
Diagnosis Recruiting nowThis study tests a new glowing needle that helps doctors find and sample very small abnormal areas inside breast ducts during surgery. The needle uses a special coating that lights up, making it easier to see and remove the right tissue. Researchers will compare how well this met…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: The Fourth Affiliated Hospital of China Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Can fish oil boost Tamoxifen's power to prevent breast cancer?
Prevention Recruiting nowThis study tests whether adding high-dose omega-3 fatty acids to low-dose tamoxifen can lower breast cancer risk more than tamoxifen alone. It includes 66 overweight or obese postmenopausal women at increased risk for breast cancer. The goal is to see if the combination improves …
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Aug 06, 2026 00:00 UTC
-
Could a lower tamoxifen dose prevent breast cancer in high-risk women?
Prevention Recruiting nowThis study is for premenopausal women at higher-than-average risk for breast cancer. It tests whether a low dose of tamoxifen can safely reduce breast density, which is linked to cancer risk. About 200 women will take tamoxifen, and doctors will adjust the dose if needed to get t…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jul 29, 2026 00:00 UTC
-
New drug acolbifene takes on tamoxifen in breast cancer prevention trial
Prevention Recruiting nowThis study tests whether acolbifene or a low dose of tamoxifen can reduce breast cancer risk in premenopausal women at high risk. Both drugs block estrogen from reaching breast cells. Researchers will measure changes in breast tissue, blood, and mammograms over six months in 80 w…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC
-
Free genetic testing offered to 27,500 people to find hidden cancer risks
Knowledge-focused Recruiting nowThis study offers free genetic testing to the general public to identify people with inherited cancer syndromes like hereditary breast and ovarian cancer or Lynch syndrome. Researchers aim to see if broad testing is more effective than only testing those with a family history. Up…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Pandemic's hidden cost: breast cancer patients face financial strain
Knowledge-focused Recruiting nowThis study looks at how the COVID-19 pandemic impacted out-of-pocket costs, lost wages, and unemployment for 600 breast cancer patients undergoing surgery. Participants will fill out questionnaires about their financial experiences. The goal is to understand the financial toxicit…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study tests whether a navigator can close gaps in breast cancer care
Knowledge-focused Recruiting nowThis study is testing a patient navigation program for women newly diagnosed with breast cancer. The program helps patients understand their care options, connect to support services, and manage barriers like transportation or finances. Researchers want to see if this approach im…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC